Related Experiment Videos
[Effect of biliary obstruction and cholangitis on serum SPan-1 level]
S Matsumoto1, T Muranaka, K Hanada
1Department of Radiology, National Fukuoka Central Hospital.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|December 1, 1990
Summary
Biliary obstruction and cholangitis significantly impact serum SPan-1 levels, particularly in biliary tract cancer patients. Post-procedure, SPan-1 changes mirrored CA 19-9 levels, suggesting similar influences from these conditions.
Area of Science:
- Gastroenterology and Oncology
- Biomarker Research
Context:
- Investigating serum tumor markers in patients with biliary obstruction and cholangitis.
- Focus on pancreatic cancer and biliary tract cancer patients undergoing percutaneous transhepatic biliary drainage (PTCD).
Purpose:
- To evaluate the effect of biliary obstruction and cholangitis on serum SPan-1 levels.
- To compare the impact on SPan-1 versus CA 19-9 levels post-PTCD.
Summary:
- Serum SPan-1 levels decreased with jaundice improvement in 8/9 biliary tract cancer patients and 1/5 pancreatic cancer patients post-PTCD.
- The influence of biliary obstruction and cholangitis on SPan-1 was more pronounced in biliary tract cancer.
- No significant difference was observed in the changes of serum SPan-1 and serum CA 19-9 levels after PTCD.
Impact:
- Serum SPan-1 levels are significantly affected by biliary obstruction and cholangitis, especially in biliary tract cancer.
- The behavior of SPan-1 changes post-PTCD is comparable to that of CA 19-9, indicating similar responses to these clinical conditions.